EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Safety and Efficacy of AlphaWave® l-Theanine Supplementation for 28 Days in Healthy Adults with Moderate Stress: A Randomized, Double-Blind, Placebo-Controlled Trial

Marc Moulin, David C Crowley, Lora Xiong, Najla Guthrie, Erin D Lewis

Neurology and Therapy · 2024-08 · 13 (4) · 1135-1153

DOI: 10.1007/s40120-024-00624-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neurology and Therapy, online erschienen am 17.05.2024. Verfasst von Marc Moulin und 4 weiteren Autor:innen. Beteiligte Einrichtung: KGK Science Inc., 275 Dundas Street, Tower A, Suite A1605, London, ON, N6B 3L1, Canada. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ethical Naturals, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Prolonged periods of stress may lead to negative health consequences. AlphaWave® L-Theanine was safe and efficacious during an acute stress challenge. However, double-blind, placebo-controlled clinical trials investigating the longer term effects of L-theanine supplementation on stress are warranted. METHODS: Thirty healthy adults (18-65 years) with moderate stress were randomized to AlphaWave® L-Theanine (400 mg L-theanine/day) or placebo (n = 15/group) for 28 days. Stress was assessed by salivary cortisol, Perceived Stress Scale (PSS) and Depression, Anxiety and Stress Scale-21; sleep was assessed by the Healthy People Sleep Quality Index and actigraphy device; cognition was assessed by Computerized Mental Performance Assessment System; mood was assessed by Profile of Mood States. All outcomes were measured at baseline, Days 14 and 28. Safety included vital signs, clinical chemistry, haematology and adverse events (AEs). RESULTS: All AEs were resolved by the end of the study period or upon subsequent follow up, and out of range laboratory values and changes in vital signs were deemed not clinically relevant following AlphaWave® L-Theanine supplementation. Participants supplemented with AlphaWave® L-Theanine had decreases of 12.92% (p = 0.051) and 17.98% (p = 0.04) in PSS scores after 14 and 28 days, respectively, while those on placebo had respective decreases of 9.74% (p = 0.061) and 17.88% (p = 0.009). There were no significant differences between groups for change in salivary cortisol. The AlphaWave® L-Theanine group demonstrated decreased time asleep after 28 days and significantly reduced light sleep after 14 and 28 days compared to placebo (p ≤ 0.040). The AlphaWave® L-Theanine group significantly improved by 21.79% and 21.33% in Stroop test correct reaction time after 14 and 28 days, respectively, while those on placebo improved after 28 days only (p = 0.005). CONCLUSIONS: AlphaWave® L-Theanine supplementation for 28 days was safe and significantly decreased perceived stress significantly decreased perceived stress and light sleep, improved sleep quality and enhanced cognitive attention in the studied population. Larger, randomized controlled trials with longer duration of AlphaWave® L-Theanine supplementation are warranted to reduce inter-individual variability and the potential placebo effect. TRIAL REGISTRATION: ClinicalTrials.gov identifier, NCT05808595.

Schlagwörter

Stichwörter der Autor:innen

l-TheanineCognitionMental healthMoodStress

Autor:innen und Institutionen

  • KGK Science Inc., 275 Dundas Street, Tower A, Suite A1605, London, ON, N6B 3L1, Canada.
  • Ethical Naturals, Inc., 2731 Fair Oaks Ave, Redwood City, CA, 94063, USA.
  • KGK Science Inc., 275 Dundas Street, Tower A, Suite A1605, London, ON, N6B 3L1, Canada. elewis@kgkscience.com.

Förderung

  • Ethical Naturals, Inc.

Zitieren

APA

Moulin, M., Crowley, D. C., Xiong, L., Guthrie, N., & Lewis, E. D. (2024). Safety and Efficacy of AlphaWave® l-Theanine Supplementation for 28 Days in Healthy Adults with Moderate Stress: A Randomized, Double-Blind, Placebo-Controlled Trial. Neurology and Therapy, 13(4), 1135-1153. https://doi.org/10.1007/s40120-024-00624-7

Vancouver

Moulin M, Crowley DC, Xiong L, Guthrie N, Lewis ED. Safety and Efficacy of AlphaWave® l-Theanine Supplementation for 28 Days in Healthy Adults with Moderate Stress: A Randomized, Double-Blind, Placebo-Controlled Trial. Neurology and Therapy. 2024;13(4):1135-1153. doi:10.1007/s40120-024-00624-7

BibTeX
@article{Moulin2024,
  author = {Moulin, Marc and Crowley, David C and Xiong, Lora and Guthrie, Najla and Lewis, Erin D},
  title = {Safety and Efficacy of AlphaWave® l-Theanine Supplementation for 28 Days in Healthy Adults with Moderate Stress: A Randomized, Double-Blind, Placebo-Controlled Trial},
  journal = {Neurology and Therapy},
  year = {2024},
  volume = {13},
  number = {4},
  pages = {1135--1153},
  doi = {10.1007/s40120-024-00624-7}
}
Kostenlos starten →